Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,055,000 | 733,000 | 726,000 | 1,007,944 | 1,021,627 |
| Marketable Securities | 4,091,000 | 3,218,000 | 3,962,000 | 4,456,935 | 3,430,816 |
| Inventories | 3,020,000 | 3,022,000 | 2,593,000 | 3,436,548 | 2,105,986 |
| Income taxes - deferred | 782,000 | 897,000 | 675,000 | N/A | N/A |
| Other current assets | 4,160,000 | 3,743,000 | 3,319,000 | 5,527,098 | 3,604,075 |
| TOTAL | $14,440,000 | $12,933,000 | $12,126,000 | $14,820,503 | $10,520,970 |
| Non-Current Assets | |||||
| PPE Net | 8,083,000 | 7,536,000 | 6,597,000 | 7,729,641 | 4,961,764 |
| Intangibles | 2,826,000 | 2,884,000 | 2,807,000 | 3,861,709 | 2,952,862 |
| Other Non-Current Assets | 267,000 | 220,000 | 46,000 | 33,183 | 10,455 |
| TOTAL | $11,176,000 | $10,640,000 | $9,450,000 | $11,624,534 | $7,925,081 |
| Total Assets | $25,616,000 | $23,573,000 | $21,576,000 | $26,445,036 | $18,446,051 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 142,000 | 152,000 | 516,000 | 460,419 | 213,586 |
| Accounts payable and accrued liabilities | 3,125,000 | 3,086,000 | 3,171,000 | 3,411,661 | 3,005,138 |
| Other current liabilities | 3,318,000 | 3,468,000 | 3,673,000 | N/A | N/A |
| TOTAL | $7,782,000 | $7,695,000 | $8,215,000 | $9,268,518 | $6,900,466 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,030,000 | 303,000 | 328,000 | 908,394 | 631,796 |
| Other Non-Current Liabilities | 603,000 | 649,000 | 543,000 | 2,453,492 | 1,344,247 |
| TOTAL | $3,315,000 | $2,621,000 | $2,135,000 | $3,413,735 | $1,996,953 |
| Total Liabilities | $11,097,000 | $10,316,000 | $10,350,000 | $12,682,252 | $8,897,419 |
| Shareholders' Equity | |||||
| Common Shares | 411,000 | 423,000 | 429,000 | 624,261 | 442,108 |
| Retained earnings | 11,606,000 | 10,449,000 | 8,451,000 | 9,874,113 | 6,961,704 |
| Other shareholders' equity | 1,851,000 | 1,857,000 | 1,889,000 | 2,735,550 | 1,887,920 |
| TOTAL | $14,418,000 | $13,178,000 | $11,172,000 | $13,710,935 | $9,527,721 |
| Total Liabilities And Equity | $25,515,000 | $23,494,000 | $21,522,000 | $26,393,187 | $18,425,140 |